
OLD Category: signatures
February 15, 2021 / Front Immunol
Ruxolitinib Cream Has Dual Efficacy on Pruritus and Inflammation in Experimental Dermatitis
February 12, 2021 / NPJ Breast Cancer
Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®
February 12, 2021 / Cancer Immunol Immunother
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
February 12, 2021 / Sci Rep
Analysis of extracellular vesicle mRNA derived from plasma using the nCounter platform
February 12, 2021 / NPJ Precis Oncol
Clinical implications of systemic and local immune responses in human angiosarcoma
February 11, 2021 / AJNR Am J Neuroradiol
Radiomics of Pediatric Low-Grade Gliomas: Toward a Pretherapeutic Differentiation of BRAF-Mutated and BRAF-Fused Tumors
February 9, 2021 / Cancer Discov
Mutations in the RAS/MAPK Pathway Drive Replication Repair–Deficient Hypermutated Tumors and Confer Sensitivity to MEK Inhibition
February 9, 2021 / Pancreatology
Gene expression profiling of morphologic subtypes of pancreatic ductal adenocarcinoma using surgical and EUS-FNB specimens
February 9, 2021 / Cancer Discov
Non-genetic evolution drives lung adenocarcinoma spatial heterogeneity and progression
February 7, 2021 / Mol Oncol
REST promotes ETS1‐dependent vascular growth in medulloblastoma
February 6, 2021 / Urol Oncol